Home > Riviste > Minerva Biotechnology and Biomolecular Research > Fascicoli precedenti > Minerva Biotecnologica 2005 September;17(3) > Minerva Biotecnologica 2005 September;17(3):127-31

ULTIMO FASCICOLO
 

JOURNAL TOOLS

Opzioni di pubblicazione
eTOC
Per abbonarsi
Sottometti un articolo
Segnala alla tua biblioteca
 

ARTICLE TOOLS

Estratti
Permessi
Share

 

  MEDICINAL PLANTS FOR BIOTECHNOLOGY AND BIOMEDICINE 

Minerva Biotecnologica 2005 September;17(3):127-31

Copyright © 2006 EDIZIONI MINERVA MEDICA

lingua: Inglese

The role of metabolic engineering for the production of secondary metabolites of plants

Khan M. T. H. 1, 2, Ather A. 2, Gambari R. 2, 3

1 Pharmacology Research Laboratory, Faculty of Pharmaceutical Sciences, University of Science and Technology, Chittagong, Bangladesh; 2 ER-GenTech, Department of Biochemistry and Molecular Biology, University of Ferrara, Ferrara, Italy; 3 Biotechnology Center, University of Ferrara, Ferrara, Italy


Full text temporaneamente non disponibile on-line. Contattaci


Plants are very interesting and useful sources of molecules of great importance for the development of new pharmaceutical products. Metabolic engineering has proven to be a valuable tool for large production of several biomedically as well as industrially relevant compounds from micro-organisms as well from higher plants. Current development of studies employing transgenic and/or recombinant technologies have opened up opportunities of the metabolic engineering/ metabolo-mics of biosynthetic pathways, leading to the growth of manufacturing of high-value secondary metabolites, even at the commercial level.

inizio pagina